Stevanato Group is a provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries. The company operates in two segments: Biopharmaceutical and Diagnostic Solutions, which includes glass primary packaging, pre-fillable syringes, ready-to-use vials, cartridges, and in-vitro diagnostic consumables; and Engineering, which covers pharmaceutical visual inspection systems, device assembly, and packaging equipment. Founded in 1949 as Soffieria Stella, the company evolved from a glassware manufacturer into an integrated solutions provider. Its global footprint includes manufacturing sites in Italy, Slovakia, Denmark, Mexico, China, Brazil, and the United States. Key acquisitions include Medical Glass, Optrel, Innoscan, Balda, Medirio, SVM Automatik, and Perugini. The company serves pharmaceutical, biotechnology, and in-vitro diagnostic customers globally, with a focus on biologics, biosimilars, vaccines, and molecular diagnostics.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage stevanatogroup.com
Sector Healthcare IR page ir.stevanatogroup.com
Tags
drug containment, drug delivery systems, in-vitro diagnostics, pharmaceutical packaging, visual inspection, autoinjectors, glass vials, pre-fillable syringes, biologics, contract manufacturing, Alba, Nexa, Fina, Aidaptus, Vertiva, sTW Needle, EZ-fill, EZ-fill Smart, Alina, Deora, MAVIS, Medical Glass, Optrel, Innoscan, Balda, Medirio, SVM Automatik, Perugini, Stevanato Group Denmark
Press page —

Metrics

Valuation  
Market cap $ 4.155B
Market cap (USD) $ 4.155B
P/E 24.03
PEG —
P/BV 2.50
P/S 3.13
P/OCF 12.98
P/FCF 166.31
Dividend yield —
Turnover / mcap —
Returns  
ROE 9.7%
ROI 7.2%
ROIC 7.6%
Profit margin 11.8%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y —
Earnings growth 3y (net profit CAGR) -0.71%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 30.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 45
Quality score 29.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 1.186B 1.104B 1.085B 983.68M 843.92M
Net profit 139.839M 117.778M 145.631M 142.849M 134.321M
Free cash flow 22.321M -146.824M -328.023M -131.717M 20.156M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 17.11 19.84 25.07 17.85 —
Price performance 12m -0.08 -0.2 0.52 -0.2 —

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Income detail
Research and development expense (EUR) 17.4M 29.6M 34.4M 35.7M 31.7M 25.4M
↳ 5y CAGR +7.9%
Reported Mar 2, 2023 Mar 2, 2023 Mar 2, 2023 Mar 7, 2024 Mar 6, 2025 Mar 4, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

"Third Quarter Financial Results Conference Call" Bull 2 Bear 0 Results

Tuesday, November 03, 2026, 14:30 CET

Moderators:

Franco Stevanato, Chairman and Chief Executive Officer

Marco Dal Lago, Chief Financial Officer

Operator:

Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the Stevanato Group Third Quarter Financial Results Conference Call. As a reminder, all participants are in listen-only mode and after the presentation, there will be an opportunity to ask questions. Should anyone need assistance during the conference call, they may signal an operator by pressing "*" and "0" on their telephone.

At this time, I would like to turn the conference over to Ms. Lisa Miles, Chief Communication & IR Officer. Please go ahead, madam.

Lisa Miles:

Please note that for today's call, we are introducing a new non-GAAP measure, organic revenue, for the purpose of offering a proper year-on-year comparison. Organic revenue is defined as reported revenue excluding the effects of divestments and/or acquisitions, and the impacts of foreign currency translation. For a reconciliation of these non-GAAP measures, please refer to the company's most recent earnings press release.

- The Company Maintains Fiscal Year 2026 Guidance -

Third Quarter of 2026 Highlights (comparisons to prior-year period)

•Revenue increased 8% to €326.1 million, and on an organic basis* revenue increased 8%.

•Revenue from high-value solutions represented 46% of total revenue.

•Gross profit was €95.0 million and gross profit margin was 29.1%.

•Adjusted EBITDA margin increased 150 basis points to 27.2%.

•Diluted earnings per share grew 15% to €0.15 and adjusted diluted earnings per share grew 14% to €0.16.

•The Company is maintaining its fiscal 2026 guidance and continues to expect revenue in the range of €1.260 billion to €1.280 billion, adjusted EBITDA of €335.0 million to €345.2 million, and adjusted diluted EPS of €0.60 to €0.62.

*Organic revenue is defined as reported revenue excluding the effects from divestments and/or acquisitions, and the impacts of foreign currency translation. Please refer to the financial table titled "Reconciliation of Revenue to Organic Revenue" included in the Non-GAAP Financial Information provided in this press release.

Safe Harbor Statement Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect the current views of Stevanato Group S.p.A. (“we”, “our”, “us”, “Stevanato Group” or the “Company”) and which involve known and unknown risks, uncertainties and assumptions because they relate to events and depend on circumstances that will occur in the future whether or not within the control of the Company. These forward-looking statements include, or may include words such as "strong," "continued," "meeting," "meet," "will continue," "deliver," "expanding," "on track," "remains," "confidence," "meaningful," "increasing," "growing," "continue," "expect," "anticipate," "driven," "robust," and other similar terminology.

Prompts

Stevanato Group S.p.A. (ticker STVN), listed in United States.

ETFs Holding Stevanato Group S.p.A.

ETF Weight in ETF Shares Market value As of
SCAP 1.60% 14,906 $ 319.436K Aug 31, 2026
TMED 0.30% 3,869 $ 69.913K Jun 30, 2026